Haura EB - Search Results

1

IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells.

Remsing Rix LL, Sumi NJ, Hu Q, Desai B, Bryant AT, Li X, Welsh EA, Fang B, Kinose F, Kuenzi BM, Chen YA, Antonia SJ, Lovly CM, Koomen JM, Haura EB, Marusyk A, Rix U. Remsing Rix LL, et al. Among authors: haura eb. Sci Signal. 2022 Aug 16;15(747):eabj5879. doi: 10.1126/scisignal.abj5879. Epub 2022 Aug 16. Sci Signal. 2022. PMID: 35973030 Free PMC article.

2

Gene therapy for lung cancer. An introduction.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Methods Mol Med. 2003;75:529-43. doi: 10.1385/1-59259-324-0:529. Methods Mol Med. 2003. PMID: 12407762 Review.

3

Gene therapy for lung cancer.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Mol Biotechnol. 2003 Oct;25(2):139-48. doi: 10.1385/MB:25:2:139. Mol Biotechnol. 2003. PMID: 14526124 Review.

4

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Simon GR, et al. Cancer Control. 2003 Sep-Oct;10(5):388-95. doi: 10.1177/107327480301000506. Cancer Control. 2003. PMID: 14581894 Free article. Clinical Trial.

5

Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.

Chiappori A, Simon G, Williams C, Haura E, Rocha-Lima C, Wagner H, Bepler G, Antonia S. Chiappori A, et al. Oncology. 2005;68(4-6):382-90. doi: 10.1159/000086979. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020967 Review.

6

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.

Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB. Song L, et al. Among authors: haura eb. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620. Cancer Res. 2006. PMID: 16740687

7

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

Zheng Z, Chen T, Li X, Haura E, Sharma A, Bepler G. Zheng Z, et al. N Engl J Med. 2007 Feb 22;356(8):800-8. doi: 10.1056/NEJMoa065411. N Engl J Med. 2007. PMID: 17314339 Free article.

8

A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.

Li J, Viallet J, Haura EB. Li J, et al. Among authors: haura eb. Cancer Chemother Pharmacol. 2008 Mar;61(3):525-34. doi: 10.1007/s00280-007-0499-3. Epub 2007 May 16. Cancer Chemother Pharmacol. 2008. PMID: 17505826

9

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

Simon G, Sharma A, Li X, Hazelton T, Walsh F, Williams C, Chiappori A, Haura E, Tanvetyanon T, Antonia S, Cantor A, Bepler G. Simon G, et al. J Clin Oncol. 2007 Jul 1;25(19):2741-6. doi: 10.1200/JCO.2006.08.2099. J Clin Oncol. 2007. PMID: 17602079 Clinical Trial.

10

Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells.

Edwards A, Li J, Atadja P, Bhalla K, Haura EB. Edwards A, et al. Among authors: haura eb. Mol Cancer Ther. 2007 Sep;6(9):2515-24. doi: 10.1158/1535-7163.MCT-06-0761. Mol Cancer Ther. 2007. PMID: 17876048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page